School of Pharmacy, University of Reading, Whiteknights, RG6 6DX Reading, UK.
Pharmaceutical Sciences Laboratory, Faculty of Science and Engineering, Åbo Akademi University, 20520 Turku, Finland.
Mater Horiz. 2023 Nov 27;10(12):5354-5370. doi: 10.1039/d3mh00717k.
In this focus article, we provide a scrutinizing analysis of transmission electron microscopy (TEM) and dynamic light scattering (DLS) as the two common methods to study the sizes of nanoparticles with focus on the application in pharmaceutics and drug delivery. Control over the size and shape of nanoparticles is one of the key factors for many biomedical systems. Particle size will substantially affect their permeation through biological membranes. For example, an enhanced permeation and retention effect requires a very narrow range of sizes of nanoparticles (50-200 nm) and even a minor deviation from these values will substantially affect the delivery of drug nanocarriers to the tumour. However, amazingly a great number of research papers in pharmaceutics and drug delivery report a striking difference in nanoparticle size measured by the two most popular experimental techniques (TEM and DLS). In some cases, this difference was reported to be 200-300%, raising the question of which size measurement result is more trustworthy. In this focus article, we primarily focus on the physical aspects that are responsible for the routinely observed mismatch between TEM and DLS results. Some of these factors such as concentration and angle dependencies are commonly underestimated and misinterpreted. We convincingly show that correctly used experimental procedures and a thorough analysis of results generated using both methods can eliminate the DLS and TEM data mismatch completely or will make the results much closer to each other. Also, we provide a clear roadmap for drug delivery and pharmaceutical researchers to conduct reliable DLS measurements.
在这篇专题文章中,我们对透射电子显微镜(TEM)和动态光散射(DLS)这两种常用方法进行了详细分析,重点研究了它们在药剂学和药物输送中的应用。控制纳米粒子的大小和形状是许多生物医学系统的关键因素之一。粒子大小将极大地影响它们穿透生物膜的能力。例如,增强渗透和保留效应需要纳米粒子的非常窄的尺寸范围(50-200nm),甚至这些值的微小偏差将极大地影响药物纳米载体向肿瘤的输送。然而,令人惊讶的是,药剂学和药物输送领域的大量研究论文报告了这两种最流行的实验技术(TEM 和 DLS)测量的纳米粒子尺寸之间存在显著差异。在某些情况下,这种差异报告高达 200-300%,这就提出了一个问题,即哪种尺寸测量结果更可信。在这篇专题文章中,我们主要关注导致 TEM 和 DLS 结果之间经常出现不匹配的物理方面。这些因素中的一些,如浓度和角度依赖性,通常被低估和误解。我们令人信服地表明,正确使用实验程序和对两种方法生成的结果进行彻底分析,可以完全消除 DLS 和 TEM 数据的不匹配,或者使结果更加接近。此外,我们为药物输送和制药研究人员提供了一条清晰的路线图,以进行可靠的 DLS 测量。